Neurada develops · patent pending

SUPRALIPIDS™

Biomimetic lipid pharmaceuticals resonant with the brain’s lipidome repertoire.

Scroll
01 Platform

Interpreting the neurolipid symphony.

Neurada deploys machine intelligence to learn the dynamics of the neurolipidome, map lipid species to brain structures, and model physiologically relevant lipids from nature-derived precursors.

/ modelDynamic neurolipidome
/ mappingMolecule-to-structure
/ inferenceAI-modeled lipid species
/ reconstructionBrain matter supply
/ 01

Model

Learning from population-scale human milk datasets, developing-brain lipidomics, and a longitudinal, high-resolution human milk × infant morphogenesis dataset.

/ 02

Map

Inferring which lipid species supply specific brain structures during construction, within a phase space defined by high-resolution biological datasets.

/ 03

Build

Translating physiologically relevant candidate architectures into neuromimetic lipids assembled from nature-derived precursors, then advancing them toward specific neuroregenerative needs.

02 Current status

Unscheduled venture,
evolving
on the go:

Asset-centric, AI-amplified.

Human at the core.
In silico at every node.
Distributed ops through resilient topology.
Resources deployed just-in-time against defined milestones.

Mortality is a supply problem.

Computational candidate selection Batch 01 complete
Lead + five candidates BBB transport testing next
Two foundational patent families Filed
Synthesis and assays Commissioning

Scientific & strategic enquiries

hq@neurada.bio